Trial · NCT01901653
Adverse events1,378
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,378
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 1 (SCLC) | 0 | 3 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 2 (SCLC) | 0 | 1 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 3 (SCLC) | 1 | 11 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 4 (SCLC) | 0 | 3 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 5 (SCLC) | 1 | 2 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 6 (SCLC) | 1 | 3 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 7 (SCLC) | 1 | 7 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 8 (SCLC) | 4 | 10 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1a: Cohort 8 (LCNEC) | 0 | 1 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1b: Retreatment (SCLC) | 5 | 18 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1b: Retreatment (LCNEC) | 1 | 2 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1b: Maintenance (SCLC) | 4 | 16 | |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1b: Maintenance (LCNEC) | 1 | 5 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1a: Cohort 1 (SCLC) | 0 | 3 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1a: Cohort 2 (SCLC) | 0 | 1 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1a: Cohort 3 (SCLC) | 0 | 11 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1a: Cohort 4 (SCLC) | 1 | 3 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1a: Cohort 5 (SCLC) | 2 | 2 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1a: Cohort 6 (SCLC) | 0 | 3 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1a: Cohort 7 (SCLC) | 1 | 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01901653/events